Anesteziologie a Intenzivni Medicina is a pivotal Czech journal dedicated to the fields of anesthesiology, critical care, and intensive medicine. Published by SOLEN SRO, this journal plays a crucial role in disseminating essential research and advancements in these vital areas of medicine. With the ISSN 1214-2158 and E-ISSN 1805-4412, it has been in publication since 2003, showcasing a wealth of knowledge that is particularly relevant to the clinical practices in the Czech Republic and beyond. Although currently classified in the Q4 quartile for both anesthesiology and critical care disciplines, the journal is committed to fostering high-quality research and clinical discussions. Researchers and healthcare professionals can benefit from its content that encompasses various aspects of patient care and procedural developments. This journal is a valuable resource for those aiming to stay updated within the fast-evolving landscape of anesthesiology and intensive medicine, despite its limited open access options. As it progresses towards its 2024 convergence year, Anesteziologie a Intenzivni Medicina strives to elevate its impact and relevance in the medical community.

Signa Vitae is a distinguished academic journal published by MRE PRESS, focusing on critical care, intensive care medicine, and emergency medicine. Established in 2008 and running through 2024, this journal serves as an essential conduit for the dissemination of innovative research and clinical practices in these dynamic fields. Based in Croatia, Signa Vitae is indexed in Scopus, highlighting its importance within the scholarly community, boasting respectable quartiles with a Q3 ranking in both Critical Care and Intensive Care Medicine and Emergency Medicine as of 2023. Although it operates under a traditional access model, the journal aims to enhance knowledge sharing and interdisciplinary dialogue among researchers, healthcare professionals, and students globally, addressing the urgent challenges and advancements in patient care. By providing a platform for high-quality studies and reviews, Signa Vitae continues to advance the conversation and practice within critical and emergency medicine.

Medicina Intensiva is a distinguished journal published by Elsevier España SLU, specializing in the critical care and intensive medicine fields. Since its inception in 1988, this peer-reviewed journal has established itself as a vital resource for healthcare professionals and researchers dedicated to advancing the knowledge and treatment of critically ill patients. With an impact factor ranked in the Q2 category for Critical Care and Intensive Care Medicine, the journal sits at the 50th percentile among its peers, reflecting its reputable standing in the academic community. The scope of the journal encompasses a wide array of topics, from clinical practices to innovative research findings, contributing significantly to the enhancement of patient care in intensive settings. Although the journal does not currently offer Open Access options, its valuable content is accessible to subscribers and institutions, reinforcing its role as an important conduit for disseminating high-quality research. As we continue into 2024, *Medicina Intensiva* remains committed to supporting the medical community through insightful articles and timely reviews that shape the future of intensive care.

Egyptian Journal of Critical Care Medicine, published by LIPPINCOTT WILLIAMS & WILKINS, serves as a vital resource in the field of critical care, providing a platform for innovative research and discussions that influence practice in intensive care settings. Established as an Open Access journal since 2013, it aims to disseminate high-quality research articles, clinical studies, and reviews that enhance understanding and application of critical care medicine. With an ISSN of 2090-7303 and an E-ISSN of 2090-9209, the journal is committed to ensuring that emerging insights and knowledge are freely available to a global audience, fostering collaboration among researchers, clinicians, and educators. Positioned within the landscape of critical care, the journal not only highlights the significance of patient management in life-threatening conditions but also promotes advancements in clinical protocols, making it essential reading for practitioners and scholars dedicated to enhancing patient outcomes in intensive care units.

Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.

Acute and Critical Care is a leading open-access journal dedicated to the fields of critical care and intensive care medicine, published by the Korean Society of Critical Care Medicine. Since its inception in 2014, this journal has provided a platform for the dissemination of high-quality research, reviews, and innovative practices aimed at improving patient outcomes in acute medical situations. With an impressive Q2 ranking in both Critical Care and Intensive Care Medicine and in Critical Care Nursing for the year 2023, it is recognized as an influential source of knowledge among professionals in the field. The journal is indexed in Scopus, with notable rankings—7th out of 27 in Critical Care Nursing and 48th out of 110 in Critical Care and Intensive Care Medicine—highlighting its credibility and relevance. Situated in Seoul, South Korea, Acute and Critical Care aims to foster collaboration and engagement within the global community of researchers, presenting cutting-edge clinical applications and advancements in patient care.

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Therapeutic Advances in Pulmonary and Critical Care Medicine is a leading journal published by SAGE Publications Ltd, dedicated to advancing the fields of pulmonary and critical care medicine. With an emphasis on innovative research, clinical practice, and therapeutic strategies, this journal aims to provide an essential platform for professionals, researchers, and students alike to share groundbreaking findings and insights in a rapidly evolving medical landscape. As an Open Access publication, it ensures that high-quality research is easily accessible to a global audience, facilitating knowledge sharing and collaboration. Though specific metrics such as H-Index and Scopus rankings are currently unlisted, the journal's commitment to rigorous peer review and high academic standards positions it as a vital resource for anyone involved in pulmonary and critical care medicine. With its dedicated editorial board and a diverse array of topics covered, Therapeutic Advances in Pulmonary and Critical Care Medicine stands at the forefront of fostering the latest advancements in the field.

JOURNAL OF INTENSIVE CARE MEDICINE, published by SAGE PUBLICATIONS INC, is a leading peer-reviewed journal dedicated to advancing the field of critical care and intensive medicine. With an ISSN of 0885-0666 and an E-ISSN of 1525-1489, this esteemed journal showcases innovative research, clinical practices, and synthesis of knowledge that informs the complexities of patient care in intensive settings. Recognized for its exceptional impact, it holds a prestigious Q1 ranking in the Critical Care and Intensive Care Medicine category, landing in the upper 15% of its field according to Scopus rankings. Celebrating over three decades of publication since its inception in 1986, the journal serves both as a resource for seasoned professionals and a platform for emerging researchers eager to contribute to evidence-based practice. Although not open access, the journal ensures that critical insights and advancements are accessible to a broad audience, fostering a collaborative environment that is essential for the evolution of intensive care protocols and the enhancement of patient outcomes. With its commitment to excellence, the JOURNAL OF INTENSIVE CARE MEDICINE stands out as an invaluable resource that continues to shape the future of healthcare in critical domains.

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.